Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Changes in plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus

P. Šimják, A. Cinkajzlová, K. Anderlová, J. Kloučková, H. Kratochvílová, Z. Lacinová, P. Kaválková, H. Krejčí, M. Mráz, A. Pařízek, M. Kršek, M. Haluzík

. 2018 ; 67 (Suppl. 3) : S531-S542.
. 2018 ; () : S531-S542.

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19005352

Grant support
NV15-27630A MZ0 CEP Register

We measured plasma concentrations, adipose tissue and placental mRNA expression of hepatokines fetuin A, fetuin B and fibroblast growth factor 21 (FGF21) in 12 healthy pregnant women (P group), 12 pregnant women with gestational diabetes (GDM) and 10 healthy non-pregnant women (N group) to explore their potential role in the etiopathogenesis of GDM. GDM and P group had comparable BMI, C-reactive protein (CRP) and glycated hemoglobin levels while IL-10 and TNF-alpha levels were higher in GDM group. Fetuin A and fetuin B levels were higher in pregnancy as compared to N group and decreased after delivery with no apparent influence of GDM. In contrast, the pattern of changes of circulating FGF21 levels differed between GDM and P group. Fetuin A concentrations positively correlated with CRP, TNF-alpha mRNA expression in adipose tissue and IL-6 mRNA expression in placenta. Fetuin B positively correlated with CRP. FGF21 levels correlated positively with IFN-gamma mRNA in adipose tissue and inversely with IL-8 mRNA in the placenta. Taken together, fetuin A and fetuin B levels were increased during pregnancy regardless of the presence of GDM. In contrast, FGF21 patterns differed between healthy pregnant women and GDM patients suggesting a possible role of this hepatokine in the etiopathogenesis of GDM.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19005352
003      
CZ-PrNML
005      
20210602141702.0
007      
ta
008      
190204s2018 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934017 $2 doi
035    __
$a (PubMed)30484680
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Šimják, Patrik $u Gynecology and Obstetrics Department, First Faculty of Medicine, Charles University and GeneralUniversity Hospital, Prague, Czech Republic $7 xx0221733
245    10
$a Changes in plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus / $c P. Šimják, A. Cinkajzlová, K. Anderlová, J. Kloučková, H. Kratochvílová, Z. Lacinová, P. Kaválková, H. Krejčí, M. Mráz, A. Pařízek, M. Kršek, M. Haluzík
520    9_
$a We measured plasma concentrations, adipose tissue and placental mRNA expression of hepatokines fetuin A, fetuin B and fibroblast growth factor 21 (FGF21) in 12 healthy pregnant women (P group), 12 pregnant women with gestational diabetes (GDM) and 10 healthy non-pregnant women (N group) to explore their potential role in the etiopathogenesis of GDM. GDM and P group had comparable BMI, C-reactive protein (CRP) and glycated hemoglobin levels while IL-10 and TNF-alpha levels were higher in GDM group. Fetuin A and fetuin B levels were higher in pregnancy as compared to N group and decreased after delivery with no apparent influence of GDM. In contrast, the pattern of changes of circulating FGF21 levels differed between GDM and P group. Fetuin A concentrations positively correlated with CRP, TNF-alpha mRNA expression in adipose tissue and IL-6 mRNA expression in placenta. Fetuin B positively correlated with CRP. FGF21 levels correlated positively with IFN-gamma mRNA in adipose tissue and inversely with IL-8 mRNA in the placenta. Taken together, fetuin A and fetuin B levels were increased during pregnancy regardless of the presence of GDM. In contrast, FGF21 patterns differed between healthy pregnant women and GDM patients suggesting a possible role of this hepatokine in the etiopathogenesis of GDM.
650    _2
$a dospělí $7 D000328
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a gestační diabetes $x krev $x diagnóza $x genetika $7 D016640
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fetální krev $x metabolismus $7 D005312
650    _2
$a fetuin B $x biosyntéza $x genetika $7 D060752
650    _2
$a fibroblastové růstové faktory $x biosyntéza $x krev $x genetika $7 D005346
650    _2
$a exprese genu $7 D015870
650    _2
$a lidé $7 D006801
650    _2
$a mediátory zánětu $x krev $7 D018836
650    _2
$a těhotenství $7 D011247
650    _2
$a messenger RNA $x biosyntéza $x genetika $7 D012333
650    _2
$a mladý dospělý $7 D055815
650    _2
$a fetuin A $x biosyntéza $x genetika $7 D060749
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cinkajzlová, Anna $7 xx0228108 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Institute of Medical Biochemistryand Laboratory Diagnostics, First Faculty of Medicine, Charles University and General UniversityHospital, Prague, Czech Republic
700    1_
$a Anderlová, Kateřina $7 xx0070229 $u Gynecology and Obstetrics Department, First Faculty of Medicine, Charles University and GeneralUniversity Hospital, Prague, Czech Republic
700    1_
$a Kloučková, Jana $7 xx0232313 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Institute of Medical Biochemistryand Laboratory Diagnostics, First Faculty of Medicine, Charles University and General UniversityHospital, Prague, Czech Republic; Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Kratochvílová, Helena, $d 1992- $7 xx0228161 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Institute of Medical Biochemistryand Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Lacinová, Zdeňka $7 xx0062138 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Institute of Medical Biochemistryand Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Kaválková, Petra $7 xx0094376 $u Institute of Medical Biochemistryand Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Krejčí, Hana, $d 1974- $7 xx0036968 $u Gynecology and Obstetrics Department, First Faculty of Medicine, Charles University and GeneralUniversity Hospital, Prague, Czech Republic
700    1_
$a Mráz, Miloš $7 xx0119173 $u Institute of Medical Biochemistryand Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Diabetes Center, Institute for Clinical and ExperimentalMedicine, Prague, Czech Republic
700    1_
$a Pařízek, Antonín, $d 1959- $7 mzk2005294935 $u Gynecology and Obstetrics Department, First Faculty of Medicine, Charles University and GeneralUniversity Hospital, Prague, Czech Republic
700    1_
$a Kršek, Michal, $d 1964- $7 xx0046428 $u Third Department of Medicine, First Faculty of Medicine,Charles University and General University Hospital, Prague, Czech Republic; Second Department of Internal Medicine, Third Faculty ofMedicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Haluzík, Martin, $d 1970- $7 xx0000707 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Institute of Medical Biochemistryand Laboratory Diagnostics, First Faculty of Medicine, Charles University and General UniversityHospital, Prague, Czech Republic; Institute ofEndocrinology, Prague, Czech Republic; Diabetes Center, Institute for Clinical and ExperimentalMedicine, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 3 (2018), s. S531-S542
773    0_
$t Dr. Karel Šilink - The 110th anniversary of the birth $g (2018), s. S531-S542 $w MED00206981
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30484680 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20190204 $b ABA008
991    __
$a 20210602141700 $b ABA008
999    __
$a ok $b bmc $g 1377925 $s 1043557
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 67 $c Suppl. 3 $d S531-S542 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2018 $d S531-S542 $m Dr. Karel Šilink - The 110th anniversary of the birth $x MED00206981
GRA    __
$a NV15-27630A $p MZ0
LZP    __
$b NLK118 $a Pubmed-20190204

Find record

Citation metrics

Archiving options